Real-life effectiveness of ustekinumab in inflammatory bowel disease patients with concomitant psoriasis or psoriatic arthritis: An IG-IBD study-Reference-Cited by-同舟云学术

Real-life effectiveness of ustekinumab in inflammatory bowel disease patients with concomitant psoriasis or psoriatic arthritis: An IG-IBD study

Published:2019-07 Issue:7 Volume:51 Page:972-977
ISSN:1590-8658
Container-title:Digestive and Liver Disease
language:en
Short-container-title:Digestive and Liver Disease

Author:

Pugliese Daniela^ORCID,Daperno Marco^ORCID,Fiorino Gionata,Savarino Edoardo,Mosso Elena^ORCID,Biancone Livia,Testa Anna^ORCID,Sarpi Lucio,Cappello Maria,Bodini Giorgia^ORCID,Caprioli Flavio^ORCID,Festa Stefano,Laino Gabriella,Maconi Giovanni^ORCID,Mazzuoli Silvia,Mocci Giammarco,Sartini Alessandro^ORCID,D’Amore Alessandra,Alivernini Stefano,Gremese Elisa,Armuzzi Alessandro^ORCID

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference36 articles.

1. IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn’s disease;Kobayashi;Gut,2008

2. STELARA® (ustekinumab) Product Monograph. Janssen (http://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/STELARA-pi.pdf).

3. Ustekinumab as Induction and Maintenance Therapy for Crohn’s disease;Feagan;N Engl J Med,2016

4. Longterm efficacy and safety of ustekinumab for Crohn’s disease: results from IM-UNITI long-term extension through 2 years;Sandborn;Aliment Pharmacol Ther,2018

5. Subcutaneous ustekinumab for the treatment of anti-TNF resistant Crohn’s disease–the McGill experience;Kopylov;J Crohns Colitis,2014

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review of dermatologic drugs relevant to inflammatory bowel disease;JAAD Reviews;2024-09

2. Extraintestinal Manifestations in Inflammatory Bowel Disease: From Pathophysiology to Treatment;Biomedicines;2024-08-13

3. Effect of ustekinumab on extraintestinal manifestations in patients with Crohn’s disease or ulcerative colitis;Meditsinskiy sovet = Medical Council;2024-06-10

4. Association between Ustekinumab Trough Levels, Serum IL-22, and Oncostatin M Levels and Clinical and Biochemical Outcomes in Patients with Crohn’s Disease;Journal of Clinical Medicine;2024-03-07

5. Ustekinumab in the Treatment of Inflammatory Bowel Diseases: Evolving Paradigms;Journal of Clinical Medicine;2024-03-06